Abstract
Presently, there is growing interest on telomerase activity in all cells (somatic cells, stem cells, cancerous cells and others) since this activity is associated with cellular changes such as proliferation, differentiation, immortalization, cell injury and ageing. Telomerase activity is absent in most of the somatic cells but present in over 90% of cancerous cells and other immortalized cell lines. In our present study, we cultured a rat embryonal liver progenitor cell line RLC-18 in a self-assembly nanostructured scaffold-coated bioreactor (NCB), collagen-coated plates (CCP) and uncoated plates (UP), and evaluated changes of telomerase activity by non radioactive techniques (Telo TAGGG Telomerase PCR ELISA, cell proliferation based on mitochondria number by MTT assay and hepatic functions such as albumin secretion, urea metabolism, Cytochrome P450 activity like ethoxyresorufin-O-deethylase (EROD) activity. We found less telomerase activity and less cell proliferation, but more hepatic functions on the NCB than on the CCP and UP. Our data support the concept that cell-scaffold interaction may play a significant in controlling the telomerase activity as well as enhanced hepatic functions. Although our present study does not focus on the exact mechanism of telomerase regulation, our result may provide basic clues on cell differentiation whereby telomerase activity inhibits differentiation of cells as in the rat embryonic liver cell line, may be regulated by cell–scaffold interaction and where there is less proliferation, cells perform enhanced hepatic functions, thereby implying that bioartificial liver support may be possible.
Similar content being viewed by others
References
Takaoka T, Yasumoto S, Katsuta H (1975) A simple method for the cultivation of rat liver cells. Jpn J Exp Med 45:317–326
Machaj EK, Grabowska I, Gajkowska A, Jastrzewska M, Oldak T et al (2005) Differentiation potential of the fetal rat liver-derived cells. Folia Histochem Cytobiol 43:217–222
Greenberg RA, Allsopp RC, Chin L, Morin GB, DePinho RA (1998) Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16:1723–1730
Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP et al (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279:349–352
Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA (1999) Creation of human tumor cells with defined genetic elements. Nature 400:464–468
Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD et al (1995) Specific association of human telomerase activity with immortal cells and cancer. Science 268:1115–1117
Rhyu S (1995) Telomeres, telomerase, and immortality. J Natl Cancer Inst 87:884–894
Sharma HW, Sokoloski JA, Perez JR, Maltese JY, Sartorelli AC et al (1995) Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 92:12343–12346
Kaito K, Narita Y, Terada S (2007) Hepatic cell lines cultured on different scaffolds and in different stages for bioartificial liver systems. In: Smith R (ed) Cell technology for cell products, Chap III. Springer, Netherlands, pp 233–238
Fu W, Begley JG, Killen MW, Mattson MP (1999) Antiapoptotic role of telomerase in pheochromocytoma cells. J Biol Chem 274:7264–7271
Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH et al (1998) Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J 12:801–811
Kanai H, Marushima H, Kimura N, Iwaki T, Saito M et al (2006) Extracorporeal bioartificial liver using the radial-flow bioreactor in treatment of fatal experimental hepatic encephalopathy. Artif Organs 31:148–151
De Bartolo L, Bader A (2001) Review of a flat membrane bioreactor as a bioartificial liver. Ann Transplant 6:40–46
Gerlach J, Schnoy N, Smith MD, Neuhaus P (1994) Hepatocyte culture between woven capillary networks: a microscopy study. Artif Organs 18:226–230
Flendrig LM, Sommeijer D, Ladiges NC, Te Veldee AA, Maas MA et al (1998) Commercially available media for flushing extracorporeal bioartificial liver systems prior to connection to the patient’s circulation: an in vitro comparative study in two and three dimensional porcine hepatocyte cultures. Int J Artif Organs 21:467–472
McKane BW, Ramachandran S, Yang J, Xu XC, Mohanakumar T (2003) Xenoreactive anti-Galalpha(1, 3)Gal antibodies prevent porcine endogenous retrovirus infection of human in vivo. Hum Immunol 64:708–717
Rozga J, Podesta L, LePage E, Hoffman A, Morsiani E et al (1993) Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure. Lancet 342:898–899
Sussman NL, Chong MG, Koussayer T, He DE, Shang TA et al (1992) Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 16:60–65
Bader A, Frühauf NR (1999) Engineering of hepatic tissue in a mini-bioreactor utilisation of the international space station. In: Wilson A, Proceedings of 2nd European symposium, ESTEC, Noordwijk, The Netherlands, ESA-SP vol 433. European Space Agency (ESA), Paris, ISBN: 9290927321, pp 499–503
Jasmund I, Bader A (2002) Bioreactor developments for tissue engineering applications by the example of the bioartificial liver. Adv Biochem Eng Biotechnol 74:100–108
Bader A, Knop E, Böker K, Frühauf N, Schüttler W et al (1995) A novel bioreactor design for in vitro reconstruction of in vivo liver characteristics. Artif Organs 19:368–374
Zhang S, Holmes T, Lockshin C, Rich A (1993) Spontaneous assembly of a self-complementary oligopeptide to form a stable macroscopic membrane. Proc Natl Acad Sci USA 90:3334–3348
Zhang S, Lockshin C, Cook R, Rich A (1994) Unusually stable beta-sheet formation in an ionic self-complementary oligopeptide. Biopolymers 34:663–672
Zhang S, Holmes T, DiPersio M, Hynes RO, Su X, Rich A (1995) Self-complementary oligopeptide matrices support mammalian cell attachment. Biomaterials 16:1385–1393
Ellis-Behnke RG, Liang YX, You SW, Tay DK, Zhang S et al (2006) Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. PNAS 103:5054–5059
Holmes TC, de Lacalle S, Su X, Liu G, Rich A, Zhang S (2000) Extensive neurite outgrowth and active synapse formation on self-assembling peptide scaffold. PNAS 97:6728–6733
Semino CE, Kasahara J, Hayashi Y, Zhang S (2004) Entrapment of hippocampal neuralcells in self-assembling peptide scaffold. Tissue Eng 10:643–655
Thonhoff JR, Lou DI, Jordan PM, Zhao X, Wu (2008) Compatibility of human fetal neural stem cells with hydrogel biomaterials in vitro. Brain Res 1187:42–51
Kisiday J, Jin M, Kurz B, Hung H, Semino CE et al (2002) Selfassembling peptide hydrogel fosters chondrocyte extracellular matrix production and cell division: implications for cartilage tissue repair. Proc Natl Acad Sci USA 99:9996–10001
Kisiday JD, Kurz B, DiMicco MA, Grodzinsky AJ (2005) Evaluation of medium supplemented with insulin-transferrin-selenium for culture of primary bovine calf chondrocytes in three-dimensional hydrogel scaffolds. Tissue Eng 11:141–145
Kisiday JD, Jin M, DiMicco MA, Kurz B, Grodzinsky AJ (2004) Effects of dynamic compressive loading on chondrocyte biosynthesis in self-assembling peptide scaffolds. J Biomech 37:595–604
Semino CE, Merok JR, Crane G, Panagiotakos G, Zhang S (2003) Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds. Differentiation 71:262–270
Wang S, Nagrath D, Chen PC, Berthiaume F, Yarmush ML (2008) Three-dimensional primary hepatocyte culture in synthetic self-assembling peptide hydrogel. Tissue Eng A 14:227–236
Davis ME, Motion JP, Narmoneva DA, Takahashi T, Hakuno D et al (2005) Injectable self-assembling peptide nanofibers create intramyocardial microenvironments for endothelial cells. Circulation 111:442–450
Narmoneva DA, Vukmirovic R, Davis ME, Kamm RD, Lee RT (2004) Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration. Circulation 110:962–968
Genové E, Shen C, Zhang S, Semino CE (2005) The effect of functionalized self-assembling peptide scaffolds on human aortic endothelial cell function. Biomaterials 26:3341–3351
Sieminski AL, Semino CE, Gong H, Kamm RD (2008) Primary sequence of ionic self-assembling peptide gels affects endothelial cell adhesion and capillary morphogenesis. J Biomed Mater Res 87:494–504
Misawa H, Kobayashi N, Soto-Gutierrez A, Chen Y, Yoshida A et al (2006) PuraMatrix facilitates bone regeneration in bone defects of calvaria in mice. Cell Transplant 15:903–910
Schneider A, Garlick JA, Egles C (2008) Self-assembling Peptide nanofiber scaffolds accelerate wound healing. PLoS ONE 3:1410
Chau Y, Luo Y, Cheung AC, Nagai Y, Zhang S et al (2008) Incorporation of a matrix metalloproteinase-sensitive substrate into self-assembling peptides—a model for biofunctional scaffolds. Biomaterials 29:1713–1719
Hamada K, Hirose M, Yamashita T, Ohgushi H (2008) Spatial distribution of mineralized bone matrix produced by marrow mesenchymal stem cells in self-assembling peptide hydrogel scaffold. J Biomed Mater Res A 84:128–136
Yoshida D, Teramoto A (2007) The use of 3-D culture in peptide hydrogel for analysis of discoidin domain receptor 1-collagen interaction. Cell Adh Migr 1:92–98
Elsdale T, Bard J (1972) Collagen substrata for studies on cell behavior. J Cell Biol 54:626–637
Bader A, Frühauf N, Zech K, Haverich A, Borlak J (1998) Development of a small scale bioreactor for drug metabolism studies maintaining hepatospecific functions. Xenbiotica 28:815–825
Schmitmeier S, Langsch A, Jasmund I, Bader A (2006) Development and characterization of a small-scale bioreactor based on a bioartificial hepatic culture model for predictive pharmacological in vitro screenings. Biotechnol Bioeng 95:1198–1206
Balis UJ, Behnia K, Dwarakanath B, Bhatia SN, Sullivan SJ et al (1999) Oxygen consumption characteristics of porcine hepatocytes. Metab Eng 1:49–62
Schafer DF, Sorrell MF (1997) Power faliure, liver faliure. New Engl J Med 336:1173–1174
Bader A, Frühauf N, Tiedge M, Drinkgern M, Zech K et al (1999) Enhanced oxygen delivery reverses anaerobic metabolic states in prolonged sandwich rat hepatocyte culture. Exp Cell Res 246:221–232
Bader A, Rinkes IHB, Closs IE, Ryan CM, Toner M et al (1992) A stable long-term hepatocyte culture system for studies of physiologic processes: cytokine stimulation of the acute phase response in rat and human hepatocytes. Biotechnol Prog 8:219–225
Langsch A, Bader A (2001) Longterm stability of phase I and phase II enzymes of porcine liver cells in flat membrane bioreactors. Biotechnol Bioeng 76:115–125
Brezden CB, Rauth AM (1996) Differential cell death in immortalized and non-immortalized cells at confluency. Oncogene 12:201–206
Grasl-Kraupp B, Ruttkay-Nedecky B, Müllauer L, Taper H, Huber W, Bursch W et al (1997) Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 25:906–912
Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW (1995) Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1:249–255
Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW et al (1995) Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 55:2734–2736
Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J 14:4240–4248
Kondo Y, Koga S, Komata T, Kondo S (2000) Treatment of prostate cancer in vitro and in vivo with 25-A anti-telomerase RNA component. Oncogene 19:2205–2211
Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG et al (1996) Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 24:1446–1451
Watanabe FD, Mullon CJP, Hewitt WR, Arkadopoulos N, Kahaku E et al (1997) Clinical experience with a bioartificial liver in the treatment of severe liver failure. Ann Surg 225:484–494
Nyberg SL, Remmel RP, Mann HJ, Peshwa MV, Hu WS, Cerra FB (1994) Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg 220:59–67
Thorgeirsson SS, Grisham JW (2003) Overview of recent experimental studies on liver stem cells. Semin Liver Dis 23:303–312
Sandhu JS, Petkov PM, Dabeva MD, Shafritz DA (2001) Stem cell properties and repopulation of the rat liver by fetal liver epithelial progenitor cells. Am J Pathol 159:1323–1334
Holmes TC (2002) Novel peptide-based biomaterial scaffolds for tissue engineering. Trends Biotech 20:16–21
Oren R, Breitman Y, Gur E, Traister A, Zvibel I et al (2005) Whole fetal liver transplantation—a new approach to cell therapy. Liver Transpl 11:929–933
Zhang S (2003) Fabrication of novel biomaterials through molecular self-assembly. Nat Biotechnol 21:1171–1178
Zhang S, Zhao X, Spirio L (2005) PuraMatrix: self-assembling peptide nanofiber scaffolds. In: Ma PX, Elisseeff J (eds) Scaffolding in tissue engineering. CRC Press, Boca Raton, FL, pp 217–238
Park YN, Chae KJ, Kim YB, Park C, Theise N (2001) Apotosis and proliferation in hepatocarcinogenesis related to cirrhosis. Cancer 92:2733–27738
De Bartolo L, Jarosch-Von Schweder G, Haverich A, Bader A (2000) A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions. Biotechnol Prog 16:102–108
Frühauf NR, Oldhafer KJ, Höltje M, Kaiser GM, Frühauf JH, Stavrou GA, Bader A, Broelsch CE (2004) A bioartificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model. Surgery 136:47–56
Acknowledgements
The authors would like to thank Angela Henning for technical assistance. This work was supported by LIVEBIOMAT (EU project NMP-013653).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giri, S., Nieber, K., Acikgöz, A. et al. Telomerase activity and hepatic functions of rat embryonic liver progenitor cell in nanoscaffold-coated model bioreactor. Mol Cell Biochem 336, 137–149 (2010). https://doi.org/10.1007/s11010-009-0266-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-009-0266-3